Cross-sectional study of the relationship of peripheral blood cell profiles with severity of infection by adenovirus type 55

Table 3 Summary of blood cell types in the different groups at the acute phase (AP) and receding pandemic (CP) phases

	Healthy controls (n = 30)	Phase	Silent infection (n = 30)	Minor infection (n = 27)	Severe infection (n = 34)	P-value
WBC, 10 ⁹ /L	5.18 ± 1.21	AP	6.03 ± 1.13	5.49 ± 1.58	6.21 ± 2.96	0.1333
WBC, 10 ⁹ /L	5.18 ± 1.21	CP	6.17 ± 1.32^b	ND	5.78 ± 1.40	0.0164^a
Neutrophil, fraction	0.57 ± 0.08	AP	0.51 ± 0.09	0.51 ± 0.14	0.61 ± 0.15^c,d	0.0020^a
Neutrophil, fraction	0.57 ± 0.08	CP	0.52 ± 0.08	ND	0.50 ± 0.09^b,e	0.0026^a
Lymphocyte, fraction	0.34 ± 0.07	AP	0.38 ± 0.08	0.34 ± 0.15	0.27 ± 0.13^c	0.0009^a
Lymphocyte, fraction	0.34 ± 0.07	CP	0.36 ± 0.08	ND	0.39 ± 0.08^e	0.0609
Monocyte, fraction	0.07 ± 0.02	AP	0.09 ± 0.02	0.13 ± 0.03^b,c	0.11 ± 0.04^b,c	<0.0001^a
Monocyte, fraction	0.07 ± 0.02	CP	0.09 ± 0.02	ND	0.09 ± 0.02^e	0.0001^a
PLT, 10 ⁹ /L	207.13 ± 36.88	AP	260.40 ± 54.22^b	213.81 ± 47.54^c	181.47 ± 48.33^c	<0.0001^a
		CP	224.37 ± 39.78^e	ND	253.00 ± 51.70^b,c,e	0.0004^a

AP, acute phase; CP, convalescent phase; ND, not determined; WBC, white blood cells; PLT, platelet.
^asignificant differences in the four groups by one-way ANOVA.
^bsignificant difference from the healthy control group.
^csignificant difference from the silent infection group.
^dsignificant difference from the minor infection group.
^esignificant difference from the AP phase within a group.

ISSN: 1471-2334